Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck
Merck
I-O blockbusters from Merck, BMS and more linked to poor COVID-19 outcomes: study
Fierce Pharma
Thu, 06/25/20 - 08:36 pm
immuno-oncology
checkpoint inhibitors
Merck
Bristol-Meyers Squibb
COVID-19
Keytruda
Opidvo
Yervoy
Genentech
Tecentriq
AstraZeneca
Imfinzi
Merck treads on Sanofi, Regeneron's turf with Keytruda's latest skin cancer OK
Fierce Pharma
Wed, 06/24/20 - 11:41 pm
Merck
Keytruda
FDA
squamous cell carcinoma
Sanofi
Regeneron
Libtayo
Yumanity and Merck Ink $500 Million+ Deal for Neurodegenerative Diseases
BioSpace
Wed, 06/24/20 - 10:28 am
Yumanity Therapeutics
Merck
ALS
frontotemporal lobar dementia
R&D
Merck’s Experimental Pneumonia Vaccine Hits the Mark in Two Phase III Studies
BioSpace
Mon, 06/22/20 - 08:38 pm
Merck
vaccines
V114
clinical trials
HIV
pneumonia
pneumococcal disease
Merck, Lilly and Amgen win again in lawsuit over drug prices in TV ads. Will it stick?
Fierce Pharma
Thu, 06/18/20 - 10:40 am
television ads
DTC ads
Merck
Eli Lilly
Amgen
drug pricing
Merck eats the lunch Bristol Myers never served, winning TMB-based OK for Keytruda
Endpoints
Wed, 06/17/20 - 10:48 am
Merck
Keytruda
Bristol-Myers Squibb
FDA
biomarkers
accelerated approvals
cancer
TMB
ADA: Merck, Pfizer's Steglatro rings up CV safety win but still lags heart-helping peers
Fierce Pharma
Tue, 06/16/20 - 06:59 pm
ADA
diabetes
Merck
Pfizer
Steglatro
FDA approves Gardasil 9, the HPV vaccine, to prevent head-and-neck cancer
Stat
Fri, 06/12/20 - 08:11 pm
Merck
FDA
vaccines
Gardasil 9
head and neck cancer
HPV
Merck & Co’s Keytruda fails in first line bladder cancer
Pharmaforum
Wed, 06/10/20 - 10:51 am
Merck
Keytruda
bladder cancer
The coronavirus vaccine frontrunners have emerged. Here's where they stand
BioPharma Dive
Tue, 06/9/20 - 12:32 pm
COVID-19
vaccines
Moderna Therapeutics
Cansino Biologics
Pfizer
BioNTech
Novavax
Inovio
Oxford BioMedica
AstraZeneca
Merck
JNJ
Sanofi
GSK
Is Moderna Really the Leader in the COVID-19 Vaccine Race?
Motley Fool
Mon, 06/8/20 - 10:36 am
vaccines
COVID-19
Moderna Therapeutics
AstraZeneca
Pfizer
JNJ
BioNTech
Merck
Sanofi
GSK
Novavax
Inovio
Merck secures FDA approval for Recarbrio to treat adults with HABP/VABP
Pharmaceutical Business Review
Mon, 06/8/20 - 10:27 am
Merck
Recarbrio
hospital-acquired bacterial pneumonia
ventilator-associated bacterial pneumonia
FDA
Report: Trump Administration Picks 5 Coronavirus Vaccine Candidates to Support
Motley Fool
Wed, 06/3/20 - 11:39 pm
vaccines
Donald Trump
Operation Warp Speed
COVID-19
Moderna Therapeutics
JNJ
Merck
Pfizer
AstraZeneca
BioNTech
With protests raging, Merck CEO Frazier urges businesses to help bridge the racial equity gap
Fierce Pharma
Tue, 06/2/20 - 10:21 am
Pharma CEOs
Merck
Ken Frazier
ethics
Marketing In another round of Merck vs. Merck, Germany-based Merck KGaA notches a win in the U.K.
Fierce Pharma
Mon, 06/1/20 - 11:39 pm
Merck
Merck KGaA
trademark
ASCO: Merck, Eisai pad case for liver cancer nod with Keytruda-Lenvima combo data
Fierce Pharma
Mon, 06/1/20 - 12:00 am
Merck
Eisai
liver cancer
ASCO 2020
Keytrua
Lenvima
clinical trials
ASCO: Merck's Keytruda doubles time to disease progression in certain colorectal cancer patients
Fierce Pharma
Thu, 05/28/20 - 11:10 pm
Merck
Keytruda
clinical trials
ASCO 2020
colorectal cancer
Merck leaps into Covid-19 vaccine race, aiming to test two different candidates this year
Stat
Tue, 05/26/20 - 11:00 am
Merck
vaccines
COVID-19
FDA Approves New Prostate Cancer Treatment From AstraZeneca and Merck
Motley Fool
Wed, 05/20/20 - 11:23 pm
AstraZeneca
Merck
Lynparza
prostate cancer
FDA
Merck Spinoff Organon Taps Ex-Allergan Execs Walsh, Stahler for C-Suite
Xconomy
Wed, 05/20/20 - 11:20 pm
Organon
Merck
Pages
« first
‹ previous
…
37
38
39
40
41
42
43
44
45
…
next ›
last »